40425_2018_463_MOESM2_ESM.docx (18.52 kB)

Additional file 2: of Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Download (18.52 kB)
journal contribution
posted on 04.12.2018, 05:00 by Fatima Karzai, David VanderWeele, Ravi Madan, Helen Owens, Lisa Cordes, Amy Hankin, Anna Couvillon, Erin Nichols, Marijo Bilusic, Michael Beshiri, Kathleen Kelly, Venkatesh Krishnasamy, Sunmin Lee, Min-Jung Lee, Akira Yuno, Jane Trepel, Maria Merino, Ryan Dittamore, Jennifer MartĂŠ, Renee Donahue, Jeffrey Schlom, Keith Killian, Paul Meltzer, Seth Steinberg, James Gulley, Jung-Min Lee, William Dahut
A. Immunophenotyping of myeloid-derived suppressor cells (MDSCs). B. Statistical analysis of pharmacodynamic endpoints. (DOCX 18 kb)

History

Exports